Notation to File

NOTE TO THE FILE

SERIAL NUMBER:            90044720

DATE:                                08/20/2020

NAME:                               csolano

NOTE:         

Searched:                                                             
     Google                            
     Lexis/Nexis                       
     OneLook
     Wikipedia
     Acronym Finder                         Protest evidence reviewed
     Other:

Checked:                                                             
     Geographic significance          
     Surname                          
     Translation
     ID with ID/CLASS mailbox

     Checked list of approved Canadian attorneys and agents

Discussed file with
Attorney/Applicant via:
        phone                               Left message with
    X   email                               Attorney/Applicant

     Requested Law Library search       X   Issued Examiner’s Amendment
     for:                                   and entered changes in TRADEUPS

        PRINT        DO NOT PRINT           Added design code in TRADEUPS
     Description of the mark
     Translation statement                  Re-imaged standard character
                                            drawing
     Negative translation statement             
     Consent of living individual           Contacted TM MADRID ID/CLASS
                                            about misclassified definite ID
     Changed TRADEUPS to:

 X   OTHER:

 

From: Lemoine, Elsa- LAW <elemoine@amgen.com>
Sent: Thursday, August 20, 2020 2:20 PM
To: Solano, Carlita <Carlita.Solano@USPTO.GOV>
Cc: Trademark Operations <tmops@amgen.com>
Subject: RE: Docket # TM-2089-US-1 - U.S. TRADEMARK APPLICATION NO. 90044720 LUMAKRAS

 

Dear Examiner Solano:

Thank you for your email below forwarding your proposed amended goods and descriptions.

Please proceed with your suggested amendment.

 

Kind regards,

 

 

Elsa Lemoine

Senior Counsel

Intellectual Property and Litigation

One Amgen Center Drive
Mail Stop 28-5-A

Thousand Oaks, CA 91320-1799

Direct Dial: (805)447-3278; Mobile: (805)279-1962

E-Mail: elemoine@amgen.com

 

This message and all attachments are a private communication that may be confidential or protected by privilege. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution or use of the information contained in or attached to this message is strictly prohibited. Please notify the sender of the delivery error by replying to this message, and then delete it from your system. Thank you.

P  Please consider the environment before printing this e-mail

 

 

 

 

 

From: Solano, Carlita <Carlita.Solano@USPTO.GOV>
Sent: Wednesday, August 19, 2020 8:07 AM
To: Lemoine, Elsa- LAW <elemoine@amgen.com>; Trademark Operations <tmops@amgen.com>
Subject: Docket # TM-2089-US-1 - U.S. TRADEMARK APPLICATION NO. 90044720 LUMAKRAS

 

Docket # TM-2089-US-1

 

Dear Ms. Lemoine,

 

I am the U.S. Patent and Trademark Office examining attorney assigned to Application Serial No. 90044720 LUMAKRAS  I have reviewed the application and the mark is almost ready for publication; however, there is an issue that needs to be addressed before the application can proceed, and this issue can be resolved by return email or over the phone:

 

Specifically, the wording “pharmaceutical preparations” identification of goods is indefinite and needs to clarify what the pharmaceuticals treat/prevent.  Additionally, the wording “amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders” needs to be clarified because it is unclear what the goods are.  I suggest the following, if accurate:

 

Class 5: Pharmaceutical preparations for use in the prevention of_____ {specify purpose, e.g. amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders}; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for use in the treatment of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders

 

With your authorization, I would be happy to enter the suggested changes for you. 

 

If you would like me to make these changes for you today to avoid a refusal of registration, just reply to this email with "OK." 

 

Please email me at your earliest convenience if you would like to resolve the issue(s) by email.   Alternatively, you can give me a call at 571-270-0348 if you would like to resolve this issue over the phone.  You can also respond to this email or leave a voice message responding to the inquiry.